Mind Medicine

Mind Medicine is a company listed under the stock ticker MNMD (US).

View the org chart displaying its 25 main executives

Most searched biographies at Mind Medicine

• Robert Barrow, Chief Executive Officer
• Brigid Makes, Director
• Roger Crystal, Director

Create your alert
to follow the executive moves at Mind Medicine.

Mind Medicine has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Mind Medicine

• MindMed Reports Third Quarter 2023 Financial Results and Business Highlights   - MindMed
• MindMed Completes Enrollment of Phase 2a Trial of MM-120 in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD) - MindMed
• MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business Update - MindMed
• MindMed to Present Data on the Preclinical Activity of MM-402 at the 36th Annual European College of Neuropsychopharmacology (ECNP) Congress - MindMed
• MindMed Completes Enrollment of Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD) - MindMed
• MindMed to Participate in the TD Cowen 3rd Annual Novel Mechanisms in Neuropsychiatry Summit - MindMed
• MindMed to Participate at September Investor Conferences - MindMed
• MindMed Secures $50.0 Million Credit Facility with K2 HealthVentures - MindMed
• MindMed Reports Second Quarter 2023 Financial Results and Business Highlights - MindMed
• MindMed Announces Exclusive License Agreement With Catalent for Its Patented Zydis® Fast-Dissolve Technology for Use with MM-120 - MindMed
• View more press releases Close

Social media about Mind Medicine

• Mind Medicine on Wikipedia, Google News & Yahoo Finance
• Mind Medicine on LinkedIn, Twitter & YouTube

Contact by email its executives including Robert Barrow

Call Mind Medicine at +41 212...

View the org chart

Register to receive your alert

Report an error